AI is already used in parts of health care, from analyzing medical images to supporting research and health-system operations. Its influence on your care depends on the specific task, the data behind the tool, how its output is evaluated, and who oversees it. AI is not one technology—and an AI-enabled system does not automatically make a clinical decision on its own.
Where AI is already showing up in health care
Some AI tools are visible to patients; others operate behind the scenes. The examples below describe uses identified by the U.S. Food and Drug Administration (FDA), the World Health Organization (WHO), and the National Academy of Medicine. They are examples of applications, not claims that every tool is widely used or improves outcomes.
As an Amazon Associate I earn from qualifying purchases.
| Setting | What AI may do | What that could mean for care |
|---|---|---|
| Clinical care and diagnosis | FDA examples include analyzing retinal images for signs of diabetic retinopathy, providing skin-cancer diagnostic information from imaging, enhancing medical images, estimating heart-attack probability, and automating insulin dosing based on continuous glucose monitor readings. | A tool may flag information, help make an image clearer, or support a defined treatment task. These examples do not establish that it replaces an eye specialist, radiologist, or treating clinician. |
| Research and medicines | WHO’s 2024 discussion paper says AI is already used in most steps of pharmaceutical development and delivery. | AI may assist work across drug development, but that fact alone does not show that a particular medicine was developed by AI or that development was faster. |
| Public health and health-system operations | WHO identifies disease surveillance, outbreak response, and health-system management as areas where AI plays a role. The National Academy of Medicine also discusses administrative automation and tools that can make complex health information easier to understand. | These uses can affect how information and services are organized without appearing as a device in a patient’s home or at the bedside. |
WHO Director-General Tedros Adhanom Ghebreyesus described the breadth of these uses: “AI is already playing a role in diagnosis and clinical care, drug development, disease surveillance, outbreak response, and health systems management … The future of healthcare is digital, and we must do what we can to promote universal access to these innovations and prevent them from becoming another driver for inequity.”
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
What AI might change in your care—and what it does not tell you
An AI system is built for a particular task: for example, analyzing a type of image, estimating a risk, or helping automate a defined process. Its output might be information for a health professional to consider, or it might be part of a system that directly affects care, such as automated insulin dosing. Those are different roles, and the label “AI” does not tell you which one applies.
#1 Best Overall
Nor does a tool’s ability to identify patterns establish that it is safe or effective for every patient or setting. Its value depends on what it was intended to do, the data used to develop and evaluate it, the population and setting in which it is used, and how it is incorporated into care. WHO notes possible value in settings with few specialists, including support for interpreting retinal scans and radiology images; that potential does not establish equal performance across populations or locations.
There is no single accuracy, savings, or patient-outcome figure that describes AI across health care. Evidence needs to be considered for the specific system and use, rather than inferred from the fact that it uses AI.
Rank #2
- Book: deep medicine: how artificial intelligence can make healthcare human again
- Language: english
- Binding: hardcover
Potential benefits and risks depend on the use
WHO and the National Academy of Medicine describe opportunities as well as concerns. A potential benefit in one task does not cancel out risks in another; both should be assessed for the actual tool and setting.
PC Slower Than It Used to Be?
A free scan shows the junk files, broken settings and background clutter dragging Windows down - then fixes them in one click.Free scan · Windows 10 & 11Crashes, No Sound, or Screen Glitches?
Random freezes, missing sound and display glitches usually trace back to one bad driver. Find and replace yours safely.Free scan · under a minute| Potential contribution | Concern to assess |
|---|---|
| Support for diagnosis, screening, and clinical care. | A diagnostic error or unsuitable treatment or risk recommendation could affect care. |
| Support for pharmaceutical research and development. | Commercial benefits may not automatically translate into public-health benefits; WHO calls for appropriate governance. |
| Administrative automation or help making complex information easier to use in shared decisions. | Incorrect or poorly presented information could mislead patients, caregivers, or health professionals. |
| Potentially useful support where specialist expertise is scarce. | Unequal data, access, or performance could worsen inequity rather than reduce it. |
| Use of data to identify patterns or support services. | Privacy, security, data misuse, cybersecurity, and bias are recognized concerns. |
These are risks to manage, not evidence that every AI tool has failed. The National Academy of Medicine also identifies unsuitable risk assessments and privacy breaches among possible harms. WHO’s ethics guidance includes human rights and equitable access, and cautions against treating AI as a substitute for core health-system investment or universal access.
Rank #3
What oversight means—and what an authorization does not prove
In the United States, device oversight depends on intended use
The FDA’s Center for Devices and Radiological Health regulates AI-enabled medical devices under the Federal Food, Drug, and Cosmetic Act. The agency describes its approach as risk-based, taking intended use and technological characteristics into account, with an aim of safety and effectiveness throughout a product’s life cycle. Not every health-related app or AI feature is necessarily an FDA-regulated medical device; intended purpose and product characteristics matter.
The FDA reports that it had authorized more than 1,600 AI-enabled medical devices for marketing in the United States as of September 2026. That dated U.S. count is not a measure of routine clinical adoption, better patient outcomes, or performance across patient groups. Authorization should not be read as a guarantee that a tool is suitable for every person or situation.
WHO highlights oversight beyond an initial review
WHO’s 2023 regulatory considerations call attention to intended use, systems that change through continuous learning, human intervention, model training, and cybersecurity threats. WHO also emphasizes dialogue among developers, regulators, manufacturers, health workers, and patients. Its 2021 ethics guidance centers human rights and identifies six consensus principles for AI to serve the public benefit; governance is broader than a single approval decision, and regulation does not eliminate every risk.
Do these 3 things before closing this tab:
1Scan for outdated or missing drivers - takes under a minute2Repair Windows errors before they cause bigger problems3Fix the driver behind crashes, sound loss and screen glitchesQuestions to ask if AI is part of your care
If a clinician or care organization tells you an AI-enabled tool is being used, you can ask practical questions about its role. The answers should clarify how it fits into your care, not require you to judge the algorithm yourself.
Best Value
- What is the tool intended to do? Ask what task it supports and what it does not decide.
- How does its output affect my care? Find out whether it is advisory or can directly change a care process or treatment.
- Who reviews the output? Ask which qualified person is responsible for interpreting it and whether that person can question or override it.
- Has it been evaluated for people and settings like mine? A tool’s performance in one population or clinical setting may not establish its performance in another.
- How is my information handled? Ask what data the tool uses and what privacy and security protections apply.
- How are updates managed? If the system can change or learn over time, ask how those changes are monitored.
For questions about a diagnosis, medication dose, or treatment change, discuss the decision with your clinician rather than relying on a general-purpose chatbot.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
